{"filing":{"accession_number":"0001193125-26-385256","cik":"0001136869","ticker":"ZBH","company_name":"ZIMMER BIOMET HOLDINGS, INC.","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-08","primary_document":"d304716d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312526385256/d304716d8k.htm"},"events":[{"id":32023,"run_id":29416,"accession_number":"0001193125-26-385256","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Kevin Thornal, Group President of Global Businesses and the Americas, is departing the company effective September 30, 2026, following a position restructuring. Thornal will receive severance benefits under the Executive Severance Plan.","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":35082,"accession_number":"0001193125-26-385256","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Kevin Thornal, Group President of Global Businesses and the Americas, is departing the company effective September 30, 2026, following a position restructuring. While the filing also discloses promotions of three other executives (Campbell, Hatcher, Kessler), the principal action disclosed in Item 5.02 is Thornal's departure and associated severance benefits under the Executive Severance Plan. The departure of a Group President-level executive is material to investors assessing leadership continuity and organizational structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:31:45.661890+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":32024,"run_id":29416,"accession_number":"0001193125-26-385256","anchor_item_number":"7.01","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Three executives were promoted effective October 1, 2026: Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data. All three will report directly to the CEO as part of a leadership restructuring designed to streamline operations.","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":35083,"accession_number":"0001193125-26-385256","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses three executive promotions effective October 1, 2026: Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data. All three will report directly to the CEO. While Kevin Thornal's departure is also mentioned, the press release centers on the promotions as the principal action (\"leadership appointments designed to streamline\"). These are material changes to the company's senior leadership structure affecting commercial strategy and execution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:31:45.661890+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35082,"accession_number":"0001193125-26-385256","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Kevin Thornal, Group President of Global Businesses and the Americas, is departing the company effective September 30, 2026, following a position restructuring. While the filing also discloses promotions of three other executives (Campbell, Hatcher, Kessler), the principal action disclosed in Item 5.02 is Thornal's departure and associated severance benefits under the Executive Severance Plan. The departure of a Group President-level executive is material to investors assessing leadership continuity and organizational structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:31:45.661890+00:00","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-09-08"},{"id":35083,"accession_number":"0001193125-26-385256","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses three executive promotions effective October 1, 2026: Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data. All three will report directly to the CEO. While Kevin Thornal's departure is also mentioned, the press release centers on the promotions as the principal action (\"leadership appointments designed to streamline\"). These are material changes to the company's senior leadership structure affecting commercial strategy and execution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:31:45.661890+00:00","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-09-08"}]}